For individuals without insurance coverage, prescription medication costs can be prohibitively expensive, but numerous options exist to significantly reduce these expenses. The most effective savings tools include discount cards (saving up to 80% at over 65,000 pharmacies nationwide), retailer discount programs offering medications for as little as $4, patient assistance programs providing free medications to eligible patients, manufacturer copay cards, and digital pharmacy platforms that offer competitive pricing. Emerging solutions like GlicRx’s employer-partnered discount cards, The Canadian Medstore’s international pharmacy network, Mark Cuban’s Cost Plus Drugs transparent pricing model, and CVS Health’s new CostVantage reimbursement system further expand accessible savings avenues. Each option has specific eligibility requirements and benefits, but combining strategies can often yield the greatest savings on necessary medications.
Prescription discount cards represent one of the most accessible ways to save on medications without insurance. These free programs can significantly reduce out-of-pocket costs at thousands of pharmacies nationwide.
GlicRx: Employer-Partnered Savings
GlicRx has emerged as a particularly valuable discount card option through partnerships with employers and benefits platforms like Gusto and Optima Benefits & Payroll. This program offers savings of up to $95 per prescription at over 60,000 pharmacies, including major chains like CVS and Walgreens. Unlike traditional insurance, GlicRx functions as a direct discount program that:
- Requires no enrollment fees or membership costs
- Can be shared with family members and pets
- Provides an average 50% discount per prescription
- Maintains compatibility with Medicare Part D plans when used outside coverage gaps
The card’s effectiveness stems from negotiated rates with pharmacy benefit managers, though savings vary by medication and pharmacy location. Users activate the card through employer portals or mobile apps, then present it at checkout instead of insurance. Notably, GlicRx cannot be combined with existing insurance benefits but serves as a powerful alternative for uninsured patients or those facing high copays.
Retailer Discount Programs
Several major retailers offer their own prescription savings programs, with recent innovations expanding price transparency and affordability.
CVS CostVantage: Transparent Reimbursement Model
In January 2025, CVS Health launched CostVantage, a groundbreaking reimbursement model that replaces traditional pharmacy markup systems with a transparent pricing formula. The program calculates medication costs using:
- Actual drug acquisition cost
- Fixed 15% markup
- Flat dispensing fee reflecting service quality
This approach eliminates cross-subsidization practices where expensive drugs offset losses on cheaper generics, potentially lowering prices for 90% of CVS Pharmacy’s commercial prescriptions. While initially targeting commercial plans, CVS plans to expand CostVantage to Medicare and Medicaid prescriptions, which could significantly benefit uninsured patients purchasing through cash-paying programs. Early analysis suggests the model may reduce out-of-pocket costs by 20-40% for common generics compared to previous pricing structures.
Digital Pharmacy Platforms
In recent years, digital pharmacy platforms have emerged as powerful tools for finding the lowest prices on prescription medications, with new entrants disrupting traditional pricing models.
Cost Plus Drugs
Launched in 2023, Mark Cuban Cost Plus Drugs employs an innovative transparent pricing model that breaks down costs into three components:
- Manufacturing expense
- 15% markup
- $5 pharmacy labor fee
This approach has reduced prices for over 1,000 medications by an average of 85% compared to traditional pharmacies. For example, the cancer drug Imatinib (400mg) costs $47.10 for a 30-day supply versus $2,502.64 at average U.S. pharmacies. The platform requires patients to have prescriptions sent directly to its partner pharmacy but offers nationwide shipping. Its condition-specific medication lists (diabetes, heart health, mental health) simplify price comparisons for chronic disease patients.
Though not restricted to just MCCPD, all cost-plus model significantly reduce financial toxicity for patients with high prescription cost through transparent pricing and supply chain simplification. Here’s how it works and its impacts:
Core Mechanism
The model calculates prices using:
- Manufacturing cost – Direct production expense
- Fixed markup – Typically 15% (MCCPDC)
- Flat fees – $3-$5 pharmacy fee + $5 shipping
This replaces traditional pharmacy pricing that includes multiple markups from wholesalers, pharmacy benefit managers (called PBMs), and insurers.
Key Patient Benefits
- Radical price reductions:
- Abiraterone (prostate cancer): $39.60/month vs $1,093 retail
- Imatinib (cancer): $47.10 vs $2,502 for 30-day supply
- Men’s health drugs: 73-100% savings vs Medicare Part D
- Transparency: Patients see actual drug costs rather than obscured pricing
- Behavioral improvements: Reduces medication rationing and prescription abandonment
Systemic Impacts
- Medicare savings potential:
- $656 million/year on abiraterone alone
- $1.1-$1.3 billion savings for 15 men’s health drugs
- Market pressure: Forces traditional pharmacies to adopt similar models (e.g., CVS CostVantage)
- Access expansion: Direct-to-consumer shipping helps rural/underserved populations
Specialty Medication Impact
Particularly transformative for:
- Cancer drugs: MCCPDC offers 90%+ savings on generics like capecitabine and methotrexate
- Chronic condition medications: 85% average savings on cardiology generics
- High-cost generics: Bypasses PBM-driven price inflation
Limitations
- Formulary restrictions: Focuses primarily on generics (1,000+ drugs vs 4,000+ at traditional pharmacies)
- Insurance incompatibility: Must choose between cost-plus pricing or insurance coverage
- Niche adoption: Still requires provider/patient education to replace entrenched purchasing habits
By eliminating middlemen and standardizing margins, the cost-plus model directly addresses the root causes of prescription price inflation, particularly for generic medications where traditional markup chains often exceed 1000%. This approach shows promise for Medicare beneficiaries and uninsured patients facing catastrophic medication costs.
The Canadian Medstore: Cross-Border Savings
Operating since 2003, The Canadian Medstore connects U.S. patients with licensed international pharmacies in Canada, the UK, and Australia to access medications at 60-80% below U.S. retail prices. Key features include:
- Personal concierge service: Dedicated agents help navigate prescription transfers and international regulations
- 4-6 week delivery: Medications ship directly from WHO-approved facilities
- Medicare Part D optimization: Helps beneficiaries avoid coverage gap penalties by sourcing non-formulary drugs internationally
The program requires valid U.S. prescriptions and accepts most payment methods, though it cannot fulfill controlled substance orders. Recent partnerships with insurance agents position it as a solution for Medicare patients facing donut hole coverage limits.
Pharmaceutical Manufacturer Coupons
Pharmaceutical companies do give coupons-commonly called manufacturer coupons, copay cards, or drug discount cards-for many brand-name prescription medications. These coupons are designed to lower the out-of-pocket costs for patients, making expensive brand-name drugs more affordable, especially when there are no generic alternatives available.
How Drug Manufacturer Coupons Work
- Purpose: Coupons are primarily a marketing tool to encourage patients to choose brand-name drugs over generics, or to help launch new products and drive demand.
- How to Get Them: Coupons are often available on the pharmaceutical company’s website, through doctors’ offices, or at pharmacies. Patients can print them at home or receive them directly.
- Who Can Use Them: Most manufacturer coupons are only available to patients with commercial insurance. People on government insurance programs like Medicare, Medicaid, or VA benefits are generally not eligible to use these coupons due to federal regulations.
- How They Are Used: Patients present the coupon at the pharmacy along with their prescription. The coupon reduces the copay or out-of-pocket cost, sometimes to as low as $0 for a limited period.
- Limitations: Coupons often have caps (e.g., up to a certain dollar amount per year), expiration dates, or usage limits (such as only for the first year or a set number of refills).
- Types:
- Copay cards/assistance programs: Reduce copay for insured patients.
- Discount cards: Offer savings at the point of sale, sometimes for uninsured or underinsured patients.
- Free trial offers: Allow patients to try a medication at no cost for a limited time.
Restrictions and Considerations
- Not for Government Insurance: Federal anti-kickback laws prohibit the use of these coupons with Medicare, Medicaid, and other government insurance plans.
- Insurance Implications: Some insurance plans use “copay accumulators,” which means the value of the coupon may not count toward your deductible or out-of-pocket maximum.
Where to find drug manufacturer coupons
There are several websites that aggregate drug manufacturer coupons and prescription discounts, making it easy to search for savings on specific medications. Some of the most widely used platforms include:
- GoodRx: Lets you search for your medication and view available coupons, including those from manufacturers, to help you pay less than the cash price at the pharmacy.
- SingleCare: Offers a drug price lookup tool that shows savings from prescription discount cards, copay assistance, and trial offers, aggregating deals from various sources.
- RxSaver: Allows you to search for medications and find coupons that can be used at thousands of pharmacies nationwide.
- ScriptSave WellRx: Provides prescription discounts and coupons that can be used at over 65,000 pharmacies.
- Optum Perks: Aggregates free prescription coupons and discount cards for a wide range of medications.
- Walgreens Rx Savings Finder: Offers a search tool to find third-party discount coupons, including those from manufacturers, for prescriptions filled at Walgreens.
These websites make it simple to compare prices, print or download coupons, and access manufacturer savings programs all in one place.
Key differences between cost-plus models in retail and mail-order pharmacies
Cost-plus pricing models are being adopted by both retail and mail-order pharmacies, but there are important distinctions in how these models are implemented and experienced by patients.
Retail Pharmacies
- Pricing Structure: Retail pharmacies using cost-plus models set prices based on the actual acquisition cost of the medication, add a transparent markup (e.g., a flat percentage or minimum fee), and include a dispensing fee.
- In-Person Access: Patients can fill prescriptions in person, often receiving medications immediately, which is beneficial for urgent needs.
- Transparency and Trust: Retail cost-plus pharmacies, such as Blueberry Pharmacy, emphasize transparency by showing patients the invoice price and the markup, building trust and loyalty.
- Insurance: Most cost-plus retail pharmacies do not accept insurance; patients pay the cost-plus price directly.
- Administrative Fees: In pass-through models, administrative fees may be higher because the plan sponsor pays the actual drug cost plus a per-claim fee, and these models are primarily limited to retail settings.
- Network Variability: Prices can vary depending on whether the pharmacy is in- or out-of-network, and discounts may be less aggressive compared to traditional models.
Mail-Order Pharmacies
- Pricing Structure: Mail-order cost-plus pharmacies, such as Mark Cuban Cost Plus Drugs (MCCPDC), also use the acquisition cost plus a fixed markup (e.g., 15%) and a flat pharmacy fee, often adding a shipping charge.
- Online Access and Delivery: Patients order medications online, and prescriptions are delivered to their homes. This is convenient for maintenance medications but may not suit urgent needs due to shipping times.
- Formulary Scope: Mail-order cost-plus pharmacies may have a more limited formulary, especially for expensive or specialty drugs; for example, MCCPDC offered only 26% of expensive generics as of May 2023.
- Insurance: Like retail cost-plus pharmacies, most mail-order cost-plus providers do not accept insurance; patients pay out-of-pocket.
- Administrative Structure: Acquisition cost plus models in the PBM space are mostly limited to PBM-owned mail or specialty pharmacies, with administrative fees and dispensing fees bundled in.
- Consistency: Mail-order cost-plus models often have more standardized pricing, as the acquisition cost is usually based on direct contracts with manufacturers or wholesalers.
Summary
- Retail cost-plus pharmacies offer immediate, in-person access and transparency, but prices may vary by location and network status, and administrative fees can be higher.
- Mail-order cost-plus pharmacies provide convenience and standardized pricing for maintenance medications, but have limitations in formulary breadth and are not suitable for urgent medication needs.
Both models increase transparency and can lower costs for many patients, but the choice between them depends on medication urgency, drug availability, and patient preferences.
Considerations
Despite the benefits of systems such as these, there are a few drawbacks that require consideration before adopting these platforms as your only source of prescription medication.
- Limited Drug Coverage
Cost-plus models like Mark Cuban’s Cost Plus Drugs (MCCPDC) focus primarily on generic medications, excluding many brand-name drugs and specialty medications (e.g., biologics, rare disease treatments). This leaves patients with complex conditions reliant on traditional pricing models for non-formulary drugs.
- Manufacturer Cost Control Risks
Pharmacies remain dependent on manufacturer pricing for drug acquisition costs. If manufacturers inflate base prices (e.g., insulin, epinephrine autoinjectors), the promised savings diminish. For example, a 15% markup on an artificially high base cost still results in unaffordable pricing.
- Insurance Incompatibility
Patients often must choose between cost-plus pricing or insurance reimbursement, as most plans don’t integrate with these models. This forces trade-offs for insured patients needing non-formulary medications.
- Variable Implementation
CVS’s CostVantage model negotiates payer-specific markups (vs. MCCPDC’s fixed 15%), creating price inconsistencies across insurers and reducing transparency. Patients may pay different prices for the same drug depending on their coverage.
- Potential for Higher Costs
- Wholesaler/manufacturer incentives: Pharmacies using cost-plus models have reduced motivation to seek lower wholesale prices, as higher acquisition costs translate to larger absolute markup revenues.
- Brand-name drug limitations: Cigna’s cost-plus model struggles with specialty/branded drugs where manufacturer pricing power negates intended savings.
- Access Challenges
- Delivery limitations: MCCPDC requires mail-order fulfillment, which may disadvantage patients needing immediate access to medications.
- Niche adoption: Many providers/pharmacies lack infrastructure to identify cost-plus options, creating coordination gaps for patients.
- Market Fragmentation
Multiple cost-plus approaches (MCCPDC, CVS, Cigna) create confusing price landscapes, requiring patients to constantly comparison-shop across incompatible systems.
While many of these platforms can reduce prices for many generics, these drawbacks highlight risks for patients requiring specialty medications, those with complex insurance coverage, and those needing urgent prescriptions. The overall effectiveness of seeking prescriptions outside of an insurance plan depends on manufacturer pricing restraint and standardized implementation across payers.
Takeaways
The prescription savings landscape continues evolving with GlicRx’s employer partnerships, Cost Plus Drugs’ disruptive pricing, Canadian Medstore’s cross-border solutions, and CVS’s transparent reimbursement model collectively expanding access to affordable medications. Uninsured patients now have unprecedented ability to comparison-shop across discount cards, international pharmacies, and reformed retail pricing structures. By strategically combining these resources with patient assistance programs and generic substitutions, most individuals can reduce medication costs by 70-90%, transforming prescription affordability from crisis to manageable expense.
If you have questions about what options are available in your area, how to access them, or any other insurance-related issues, do not hesitate to reach out so that we can talk.
- Saving on prescription medications without insurance - May 15, 2025
- What Makes One Medicare Supplement Plan Better Than Another from a Different Insurance Company? - May 12, 2025
- How your health insurance subsidy is calculated - April 28, 2025
